Microanticorpo (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Microanticorpo" in Galician language version.

refsWebsite

Global rank Galician rank

4^th place

6^th place

2^nd place

7^th place

low place

1,154^th place

1,226^th place

970^th place

1,903^rd place

1,398^th place

bmj.com

Rietveld E, Steyerberg EW, Polder JJ, Veeze HJ, Vergouwe Y, Huysman MW, de Groot R, Moll HA (2010). "Passive immunisation against respiratory syncytial virus: a cost-effectiveness analysis". Archives of Disease in Childhood 95 (7): 493–8. PMID 20504841. doi:10.1136/adc.2008.155556.

Heap CJ, Wang Y, Pinheiro TJ, Reading SA, Jennings KR, Dimmock NJ (2005). "Analysis of a 17-amino acid residue, virus-neutralizing microantibody". The Journal of General Virology 86 (Pt 6): 1791–800. PMID 15914858. doi:10.1099/vir.0.80812-0.
Rietveld E, Steyerberg EW, Polder JJ, Veeze HJ, Vergouwe Y, Huysman MW, de Groot R, Moll HA (2010). "Passive immunisation against respiratory syncytial virus: a cost-effectiveness analysis". Archives of Disease in Childhood 95 (7): 493–8. PMID 20504841. doi:10.1136/adc.2008.155556.
Bakker JM, Bleeker WK, Parren PW (2004). "Therapeutic antibody gene transfer: an active approach to passive immunity". Molecular Therapy : the Journal of the American Society of Gene Therapy 10 (3): 411–6. PMID 15336642. doi:10.1016/j.ymthe.2004.06.865.

Heap CJ, Wang Y, Pinheiro TJ, Reading SA, Jennings KR, Dimmock NJ (2005). "Analysis of a 17-amino acid residue, virus-neutralizing microantibody". The Journal of General Virology 86 (Pt 6): 1791–800. PMID 15914858. doi:10.1099/vir.0.80812-0.

Heap CJ, Wang Y, Pinheiro TJ, Reading SA, Jennings KR, Dimmock NJ (2005). "Analysis of a 17-amino acid residue, virus-neutralizing microantibody". The Journal of General Virology 86 (Pt 6): 1791–800. PMID 15914858. doi:10.1099/vir.0.80812-0.
Rietveld E, Steyerberg EW, Polder JJ, Veeze HJ, Vergouwe Y, Huysman MW, de Groot R, Moll HA (2010). "Passive immunisation against respiratory syncytial virus: a cost-effectiveness analysis". Archives of Disease in Childhood 95 (7): 493–8. PMID 20504841. doi:10.1136/adc.2008.155556.
Bakker JM, Bleeker WK, Parren PW (2004). "Therapeutic antibody gene transfer: an active approach to passive immunity". Molecular Therapy : the Journal of the American Society of Gene Therapy 10 (3): 411–6. PMID 15336642. doi:10.1016/j.ymthe.2004.06.865.
Cattaneo A (2010). "Tanezumab, a recombinant humanized mAb against nerve growth factor for the treatment of acute and chronic pain". Current Opinion in Molecular Therapeutics 12 (1): 94–106. PMID 20140821.
Fujii I (2009). "[Beyond antibodies: generation of conformationally constrained peptides for molecular-targeting therapy]". Yakugaku Zasshi 129 (11): 1303–9. PMID 19881201.